1
项与 Donor NK Cell(Peking University First Hospital) 相关的临床试验A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined with Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.
This is a single-centre, single-arm, open-label, early clinical study to evaluate the safety, tolerability and preliminary efficacy of donor NK cells injection combined with low-dose interleukin-2 in the treatment of acute myeloid leukemia (AML) relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
100 项与 Donor NK Cell(Peking University First Hospital) 相关的临床结果
100 项与 Donor NK Cell(Peking University First Hospital) 相关的转化医学
100 项与 Donor NK Cell(Peking University First Hospital) 相关的专利（医药）
100 项与 Donor NK Cell(Peking University First Hospital) 相关的药物交易
